We previously found that numbers of ARID3a+ B cells were dramatically increased in SLE patients compared to healthy controls, and that numbers of ARID3a+ B cells in those patients were associated with increased disease activity [3]. This evidence concerns the gene ARID3A and systemic lupus erythematosus.